Cardio Diagnostics Holdings, Inc. financial data

Symbol
CDIO, CDIOW on Nasdaq
Industry
In Vitro & In Vivo Diagnostic Substances
Location
311 W. Superior Street, Suite 444, Chicago, IL
State of incorporation
DE
Fiscal year end
December 31
Former names
Mana Capital Acquisition Corp. (to 10/26/2022)
Latest financial report
10-Q - Q3 2024 - Nov 13, 2024

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 458 %
Debt-to-equity 35.4 % -68.7%
Return On Equity -259 % +10.7%
Return On Assets -191 % -40.4%
Operating Margin -23.5K % +63%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 40.4M shares +97.1%
Common Stock, Shares, Outstanding 30.3M shares +131%
Entity Public Float 9.4M USD -85.4%
Common Stock, Value, Issued 303 USD +131%
Weighted Average Number of Shares Outstanding, Basic 24.4M shares +105%
Weighted Average Number of Shares Outstanding, Diluted 24.4M shares +105%

Income Statement

Label TTM Value / Value Unit Change %
Revenues 35.7K USD +181%
Research and Development Expense 30.9K USD -81.7%
Selling and Marketing Expense 188K USD +31.7%
General and Administrative Expense 8.19M USD +5.51%
Operating Income (Loss) -8.39M USD -3.8%
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest -8.25M USD +11.9%
Income Tax Expense (Benefit) 0 USD
Net Income (Loss) Attributable to Parent -8.25M USD +11.9%
Earnings Per Share, Basic -0.32 USD/shares +81.9%
Earnings Per Share, Diluted -0.32 USD/shares +81.9%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 0 USD
Accounts Receivable, after Allowance for Credit Loss, Current 14.1K USD +3929%
Assets, Current 2.63M USD -41.9%
Property, Plant and Equipment, Net 707K USD +1798%
Operating Lease, Right-of-Use Asset 575K USD 0%
Assets 4.48M USD -24.8%
Accrued Liabilities, Current 1.98K USD
Liabilities, Current 309K USD -89.6%
Operating Lease, Liability, Noncurrent 663K USD 0%
Liabilities 795K USD -78.4%
Retained Earnings (Accumulated Deficit) -21.2M USD -63.6%
Stockholders' Equity Attributable to Parent 3.69M USD +61.1%
Liabilities and Equity 4.48M USD -24.8%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities -1.23M USD +25.2%
Net Cash Provided by (Used in) Financing Activities 1.58M USD -63.1%
Net Cash Provided by (Used in) Investing Activities -69.9K USD -32.8%
Common Stock, Shares Authorized 300M shares 0%
Common Stock, Shares, Issued 30.3M shares +131%
Common Stock, Par or Stated Value Per Share 0 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 1.98M USD -45.4%
Interest Paid, Excluding Capitalized Interest, Operating Activities 5.82K USD -34.4%
Deferred Tax Assets, Valuation Allowance 4.71M USD +162%
Deferred Tax Assets, Gross 4.71M USD +162%
Operating Lease, Liability 720K USD -19.8%
Depreciation 78.8K USD +2570%
Payments to Acquire Property, Plant, and Equipment 20K USD
Lessee, Operating Lease, Liability, to be Paid 771K USD -21.7%
Operating Lease, Liability, Current 224K USD 0%
Lessee, Operating Lease, Liability, to be Paid, Year Two 261K USD 0%
Lessee, Operating Lease, Liability, to be Paid, Year One 64.8K USD -74.8%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount 50.7K USD -41.5%
Lessee, Operating Lease, Liability, to be Paid, Year Three 250K USD 0%
Deferred Tax Assets, Operating Loss Carryforwards 4.22M USD +162%
Preferred Stock, Shares Issued 0 shares
Preferred Stock, Shares Authorized 100M shares 0%
Lessee, Operating Lease, Liability, to be Paid, Year Four 102K USD 0%
Operating Lease, Payments 64.1K USD
Additional Paid in Capital 24.9M USD +63.2%
Preferred Stock, Shares Outstanding 0 shares
Amortization of Intangible Assets 16K USD 0%
Deferred Tax Assets, Net of Valuation Allowance 0 USD
Interest Expense -1.61M USD -99.3%
Preferred Stock, Par or Stated Value Per Share 0 USD/shares 0%